Search for: "Marshall v. Beall" Results 1 - 1 of 1
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2014, 12:23 am by FDABlog HPM
  As the FDA panelist at the hearing, Janet Woodcock, Director of FDA’s Center for Drug Evaluation and Research (“CDER”), discussed how CDER is working to advance development and improve the use of PROs under the Prescription Drug User Fee Act V (“PDUFA V”). [read post]